𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Diurnal variation of serum alanine transaminase activity in chronic liver disease

✍ Scribed by Juan Córdoba; Ken O'Riordan; Josée Dupuis; Jayme Borensztajn; Andres T. Blei


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
36 KB
Volume
28
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


The determination of serum levels of alanine transaminase (ALT) is a critical tool in the diagnosis and follow up of patients with liver disease. We were interested in the recent article by Piton et al., 1 which identified factors associated with ALT variability from a cohort of 1,033 blood donors and estimated the clinical impact of correcting the normal upper limit value of ALT according to these parameters. However, the authors did not mention if blood sampling was obtained at the same time of the day and if they assessed the role of this factor on ALT values. In healthy individuals there is a such a variation of ALT 2 and other blood analytes 3 of low amplitude that does not pose diagnostic problems. However, in patients with high values of ALT, the changes could be of significance. Different biological rhythms have been shown to be abnormal in patients with cirrhosis 4-6 and in rats with portacaval anastomosis. It is unknown whether a common abnormality may also affect the diurnal variation of ALT.

We examined the diurnal variation of serum ALT in a group of 12 patients with cirrhosis (5 men, 7 women; 35-63 years; mean age, 47 years) of different etiologies (5 alcoholic, 4 hepatitis C, and 3 primary biliary cirrhosis) staged Child-


📜 SIMILAR VOLUMES


Serum lysyl oxidase activity in chronic
✍ Dr. Yoshikazu Murawaki; Yuka Kusakabe; Chisato Hirayama 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 759 KB

Lysyl oxidase was partially purified from serum by a diethylaminoethyl batch procedure in the presence of 6 mom urea and dialyzed against 3 molL KSCN. Using this method, we determined serum lysyl oxidase activity in 52 patients with liver disease and in 14 healthy controls, and we examined usefulnes

Serum 7α-hydroxycholesterol as a new par
✍ Syoji Kuroki; Shuichiro Okamoto; Tokio Naito; Hitoshi Oda; Shoji Nagase; Hironor 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 680 KB

To examine bile acid synthesis in chronic liver diseases, serum total 7a-hydroxycholesterol level was measured by gas-liquid chromatography-mass spectrometry in patients with cirrhosis (n = 23), patients with chronic hepatitis (n = 21), and control subjects (n = 18). The serum 7a-hydroxycholesterol

Elevated serum alanine aminotransferase
✍ George N. Ioannou; Noel S. Weiss; Edward J. Boyko; Dariush Mozaffarian; Sum P. L 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 1 views

In the United States, elevated serum alanine aminotransferase (ALT) activity in the absence of viral hepatitis or excessive alcohol consumption is most commonly attributed to nonalcoholic fatty liver disease (NAFLD). NAFLD is related to predictors of coronary heart disease (CHD) such as insulin resi

The N-Terminal Propeptide of Collagen Ty
✍ Alain Frei; Arthur Zimmermann; Kurt Weigand 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 592 KB

To evaluate the diagnostic significance of the collagen Type I11 (Col 1-3) N-terminal propeptide of procollagen Type 111, with respect to activity and degree of liver fibrosis, Col 1-3 serum concentrations were measured in 11 1 patients with chronic liver diseases and in 60 patients were correlated

Relationship between serum and hepatic 7
✍ T Suou; S Yamada; K Hosho; N Yoshikawa; H Kawasaki 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

We evaluated the mechanism of increased serum con-gens can cause increased levels of serum collagen-recentrations of the 7S fragment of the N-terminal domain lated antigens such as the 7S fragment of the Nof type IV collagen (7S collagen) in chronic liver disease. terminal domain of type IV collagen